CelAgace™ OraRinse Solution for Treatment of Candidiasis

NCT03250923 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidiasis, Oral

Interventions

DRUG: silver citrate complex and acemannan

Sponsor

CelaCare Technologies, Inc.

Collaborators

[object Object]